Drag Pharma

Cabatina® Oral solution

Antihemorrhagic

Cabatina® is a product indicated for the treatment of poisoning caused by anticoagulant rodenticides and hemorrhagic processes related to the defective formation of Vitamin K-dependent coagulation factors.

Data Sheet

Oral solution.

Antihemorrhagic.

Dogs and cats.

Vitamin K is a cofactor in the last stage of hepatic synthesis of coagulation factors II (Prothrombin), VII (Proconvertin), IX (Plasma Thromboplastin Component) and X (Stuart Factor).
The process of formation of vitamin K-dependent coagulation factors can be interrupted for various reasons, such as congenital diseases, vitamin K deficiency as a result of low dietary intake, malabsorption syndromes, extensive broad-spectrum antibiotic therapies or others. In Veterinary Medicine, the most frequent cause of cessation of formation of K-dependent coagulation factors is poisoning by anticoagulant rodenticides.
Vitamin K1 antagonizes the effects of anticoagulant rodenticides and allows the production process of K-dependent coagulation factors to be reactivated.

Each 1 mL of product contains:
Vitamin K1 (Phytomenadione)………………..20 mg
Excipients q.s.………………………………………..……1 mL

Cabatina® is a product indicated for the treatment of poisoning caused by anticoagulant rodenticides and hemorrhagic processes related to the defective formation of Vitamin K-dependent coagulation factors.

Orally.

Dose of the active ingredient:

  • Dogs: 2 mg/Kg of Vitamin K1, once a day, for 3 weeks.
  • Cats: 5 mg/Kg of Vitamin K1, once a day, for 3 weeks.

Product dosage:

  • Dogs: 1mL of  Cabatina® for every 10Kg of body weight, once a day, for 3 weeks.
  • Cats: 1 mL of Cabatina® per 4 Kg of body weight, once a day, for 3 weeks.

To improve its absorption, it is recommended to administer Cabatin together with a tablespoon of canned dog or cat food.

  • Keep out of reach of children and pets.
  • This product does not correct hypoprothrombinemia resulting from hepatocellular damage.

The following medications may prolong or potentiate the effects of anticoagulants and antagonize some of the therapeutic actions of Vitamin K1: Phenylbutazone, Aspirin, Chloramphenicol, Sulfonamides (including Sulfa/Trimethoprim), Diazoxide, Allopurinol, Cimetidine, Metronidazole, anabolic steroids, Erythromycin , Ketoconazole, Propranolol and thyroid drugs.
Co-administration of Vaseline may decrease the absorption of Vitamin K.

  • In case of contact with the skin, it is recommended to wash your hands with soap and plenty of water. If irritation develops and persists, consult a doctor.
  • In the case of contact with eyes, it is recommended to wash with plenty of water for 15 minutes. If irritation develops and persists, consult a doctor.
  • If swallowed, do not induce vomiting. Get medical help.
  • Do not administer to animals with known hypersensitivity to Vitamin K.
  • Do not administer to animals with severe liver failure.

Discard unused product remains in their original packaging. Dispose of waste from this product with caution with household waste. Contact the manufacturing company or companies specialized in waste disposal to receive recommendations on the disposal of expired or unused products.

Store at a temperature between 15 and 30°C, protected from light. Once opened, use within 8 weeks. Discard unused product after that period of time.

Sale under Veterinary Medical prescription.

VETERINARY USE

Chile: Reg. SAG N° 2096
Bolivia: Reg. SENASAG PUV-No 009805/21
Perú: Reg. SENASA F.77.32.I.0053
Costa Rica: Reg. N° MV-7129

Bottle with 25 mL.

Laboratorio Drag Pharma Chile Invetec S.A
Lautaro N° 300. Quilicura. Santiago. Chile.

*Important:

You have accessed information referring to pharmaceutical products authorized for sale under a medical prescription. In accordance with Chilean legislation, the promotion and advertising of these products is restricted to professionals who prescribe and dispense them. The information contained on this page is specialized technical and scientific information.